Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 433.25 INR 0.97% Market Closed
Market Cap: 26.5B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

Panacea Biotec Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Panacea Biotec Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Panacea Biotec Ltd
NSE:PANACEABIO
Other Long-Term Assets
â‚ą464.4m
CAGR 3-Years
50%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Other Long-Term Assets
â‚ą302.1m
CAGR 3-Years
22%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Other Long-Term Assets
-â‚ą8.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Other Long-Term Assets
â‚ą48.9m
CAGR 3-Years
253%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Hester Biosciences Ltd
NSE:HESTERBIO
Other Long-Term Assets
â‚ą20.1m
CAGR 3-Years
-44%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Other Long-Term Assets
â‚ą5.9B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
14%
No Stocks Found

Panacea Biotec Ltd
Glance View

Market Cap
26.5B INR
Industry
Biotechnology

Panacea Biotec Ltd. is a biotechnology company, which is engaged in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product portfolio includes pain management, diabetes & cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines. The Company’s subsidiaries include Panacea Biotec Pharma Limited, Panacea Biotec (International) SA, PanEra Biotec Private Limited and Meyten Realtech Private Limited.

PANACEABIO Intrinsic Value
178.94 INR
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Panacea Biotec Ltd's Other Long-Term Assets?
Other Long-Term Assets
464.4m INR

Based on the financial report for Sep 30, 2024, Panacea Biotec Ltd's Other Long-Term Assets amounts to 464.4m INR.

What is Panacea Biotec Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
2%

Over the last year, the Other Long-Term Assets growth was -5%. The average annual Other Long-Term Assets growth rates for Panacea Biotec Ltd have been 50% over the past three years , 2% over the past five years .

Back to Top